HealthcareNYSE
Institutional-grade research for retail investors
SEC EDGAR: CIK 1804176BFLY stock profile & AI dashboard →

13F Pro Quality Score

29.5/100

Rank #2,407 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

78.6/100

Profitability

8.5/100

Balance Sheet

9.3/100

Earnings Quality

30.0/100

Free Cash Flow

10.1/100

Institutional Flow

94.3/100

Revenue Scale

16.8/100

Dilution Risk

7.8/100

BFLY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Butterfly Network, Inc. (BFLY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BFLY at 29.5/100 on a 32-signal composite quality model, placing it at rank #2,407 of 2,879 stocks — the bottom half of the AI-ranked universe. BFLY scores in the top quartile across institutional flow (94.3), revenue growth (78.6). Areas of concern include profitability (8.5) and balance sheet strength (9.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 7.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Butterfly Network, Inc. reports quarterly revenue of $26.5M, net income of $-12.7M, free cash flow of $-14.8M. Top institutional holders of BFLY by reported 13-F value include BlackRock,, GLENVIEW CAPITAL MANAGEMENT,, Fosun International Ltd, based on the most recent SEC filings. BFLY trades on the NYSE exchange and files with the SEC under CIK 1804176. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BFLY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Butterfly Network, Inc. directly from SEC EDGAR. Butterfly Network, Inc.'s 13F Pro composite quality score has ranged between 8 and 52 since 2022, currently 29.5 — an improving long-term trajectory across 52 quarterly and live scoring snapshots.

Fun facts about Butterfly Network, Inc.

Quirks, history, and lore behind BFLY — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. medical device company · listed on NYSE · headquartered in Connecticut · operates in the diagnostic imaging space.
  • 2
    The Numbers
    A small-cap company with annual revenue in the range of tens of millions of dollars — burning cash as it scales, which is pretty on-brand for a hardware startup trying to reinvent a century-old technology.
  • 3
    The History
    Founded around 2011 and spun out of research at Yale University, it went public via a SPAC merger in 2021 — riding the wave of blank-check enthusiasm like a true child of its era.
  • 4
    The Secret
    Its core innovation is cramming an entire ultrasound machine onto a single semiconductor chip, replacing bulky carts worth tens of thousands of dollars with something you can hold in one hand.
  • 5
    The Lore
    The company counts Bill Gates among its early high-profile backers, and its device has been used in remote and battlefield settings where dragging a hospital cart is simply not an option.
  • 6
    The Giveaway
    Its handheld, whole-body ultrasound device plugs into a smartphone and is named the Butterfly iQ — because apparently stethoscopes are so last century.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$26.5M

Net Income

Q1 2026

$-12.7M

Free Cash Flow

Q1 2026

$-14.8M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+19.0% YoY
$97.6MFY 2025
FY22 $73.4MFY23 $65.9MFY24 $82.1MFY25 $97.6M

Net Income

-6.3% YoY
$-77.1MFY 2025
FY22 $-168.7MFY23 $-133.7MFY24 $-72.5MFY25 $-77.1M

Operating Income

-16.1% YoY
$-86.4MFY 2025
FY22 $-193.0MFY23 $-145.6MFY24 $-74.4MFY25 $-86.4M

EPS (Diluted)

+8.8% YoY
$-0.31FY 2025
FY22 $-0.84FY23 $-0.65FY24 $-0.34FY25 $-0.31

Total Assets

+15.8% YoY
$296.5MFY 2025
FY22 $417.6MFY23 $304.3MFY24 $256.1MFY25 $296.5M

Op. Cash Flow

+69.5% YoY
$-12.7MFY 2025
FY22 $-169.1MFY23 $-98.8MFY24 $-41.7MFY25 $-12.7M

AI Insight: BFLY Financial Trends

Revenue jumped 45% to $32M in Q4 2025 but fell back to $27M in Q1 2026, while losses persist despite some margin improvement.

Revenue volatility evident with Q4 2025 spike to $32M followed by decline to $27M in Q1 2026.

Operating losses improved from $-35M in Q3 2025 to $-14M in Q1 2026.

Net losses narrowed from $-34M in Q3 2025 to $-13M in Q1 2026.

Operating cash flow turned negative to $-14M in Q1 2026 after positive $9M in Q4 2025.

Equity declined from $240M in Q1 2025 to $191M in Q1 2026 amid continued losses.

AI Insight: BFLY Ratio Trends

Operating margin improved meaningfully from -163.5% in Q3 2025 to -52.3% in Q1 2026, though company remains deeply unprofitable.

Operating margin improved from -163.5% in Q3 2025 to -52.3% in Q1 2026, recovering from exceptional weakness.

Net profit margin strengthened from -158.1% in Q3 2025 to -47.8% in Q1 2026.

ROIC improved from -69.0% in Q3 2025 to -29.0% in Q1 2026, still deeply negative.

Company remains deeply unprofitable with TTM operating margin at -79.5% despite recent quarterly improvements.

Q3 2025 showed severe deterioration across all metrics before Q4 2025 recovery began.

Get alerted when BFLY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Butterfly Network, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of BFLY

Put BFLY on your watchlist

Track score changes the day Butterfly Network, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is BFLY a good stock to buy?

13F Pro's AI-powered analysis of Butterfly Network, Inc. (BFLY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BFLY are available on the BFLY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own BFLY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BFLY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Butterfly Network, Inc.'s investment landscape.